Ester Forastiere

Ester Forastiere

Auto-generated profile, based on publicly available information

Ester Forastiere

Department of Anesthesiology, Regina Elena National Cancer Institute, Rome, Italy

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2009 in European Urology
Verified
Journal Article
Closed access
GSGiuseppe Simone
Giuseppe Simone
RPRocco Papalia
Rocco Papalia
SGSalvatore Guaglianone
Salvatore Guaglianone
MFMariaconsiglia Ferriero
Mariaconsiglia Ferriero
CLCostantino Leonardo
Costantino Leonardo
MGMichele Gallucci
Michele Gallucci

1 December 2008 in British Journal of Anaesthesia
Verified
Journal Article
Open access
PDF file
EFE. Forastiere
E. Forastiere
MSM. Sofra
M. Sofra
DGDiana Giannarelli
Diana Giannarelli
LFL. Fabrizi
L. Fabrizi
GSGiuseppe Simone
Giuseppe Simone
Block of parietal nociceptive afferent nerves using continuous wound infiltration with local anaesthetics may be beneficial in multimodal postoperative pain management. The effectiveness of continuous wound infusion of ropivacaine for postoperative pain relief after open nephrectomy was analysed in a prospective, randomized, double-blinded, placebo-controlled trial. One hundred and sixty-eight patients were randomized to either 0.5% ropivacaine (ON-Q group) or 0.9% NaCl (control group), using an elastomeric pump which delivered 4 ml h−1 over 48 h through two multiholed Soaker® catheters placed between the transverse and the internal oblique muscles and the s.c. space. All patients received a standard postoperative pain management protocol, including patient-controlled analgesic morphine and ketorolac. Outcomes measured over 48 h after operation were visual analogue scale (VAS) and incident (i) VAS pain scores, morphine consumption, and side-effects; time to bowel function recovery; and mean length of hospitalization. Side-effects were similar between the two groups. VAS and i-VAS pain scores, morphine consumption [11.5 (0.27) vs 21.8 (0.37) mg; P<0.001], time to bowel recovery [21.8 (0.4) vs 33.6 (0.9) h; P<0.001], and mean length of hospitalization [2.1 (0.03) vs 3.2 (0.1) days; P<0.001] were significantly reduced in the ON-Q group. Cost analysis revealed an overall savings of ∼273 euros per patient in the ON-Q group. Continuous surgical wound infusion with ropivacaine improved pain relief and accelerated recovery and discharge reducing overall costs of care.

1 April 2015 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
LCLuca Colantonio
Luca Colantonio
CCClaudia Claroni
Claudia Claroni
LFLuana Fabrizi
Luana Fabrizi
MMMaria Elena Marcelli
Maria Elena Marcelli
MSMaria Sofra
Maria Sofra
EFEster Forastiere
Ester Forastiere

7 March 2013 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
EVEnrico Vizza
Enrico Vizza
GCGiacomo Corrado
Giacomo Corrado
EMEmanuela Mancini
Emanuela Mancini
EBErmelinda Baiocco
Ermelinda Baiocco
LPLodovico Patrizi
Lodovico Patrizi
EFEster Forastiere
Ester Forastiere

29 August 2019 in Pain Medicine
Verified
Journal Article
Closed access
MCmarco covotta
marco covotta
CCClaudia Claroni
Claudia Claroni
Manuela CostantiniManuela Costantini
Manuela Costantini
GTGiulia Torregiani
Giulia Torregiani
LPLorella Pelagalli
Lorella Pelagalli
EFEster Forastiere
Ester Forastiere
Background: Use of a locoregional analgesia technique, such as the ultrasound-guided transversus abdominis plane block (TAPb), can improve postoperative pain management. We investigated the role of TAPb in robotic partial nephrectomy, a surgery burdened by severe postoperative pain.Methods: In this prospective trial, patients with American Society of Anesthesiologists class I–III physical status undergoing robotic partial nephrectomy were randomly assigned to standard general anesthetic plus ultrasound-guided TAPb (TAP group) or sole standard general anesthetic (NO-TAP group). The primary end point was morphine consumption 24 hours after surgery. Secondary outcomes were postoperative nausea and vomiting in the first 24 hours, sensitivity, and acute and chronic pain, as measured by multiple indicators.Results: A total of 96 patients were evaluated: 48 patients in the TAP group and 48 in the NO-TAP group. Median morphine consumption after 24 hours was higher in the NO-TAP group compared with the TAP group (14.1 ± 4.5 mg vs 10.6 ± 4.6, P < 0.008). The intensity of acute somatic pain and the presence of chronic pain at three and six months were higher in the NO-TAP group.Conclusions: Our results show that TAPb can significantly reduce morphine consumption and somatic pain, but not visceral pain. TAPb reduced the incidence of chronic pain.

30 September 2012 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
RPRocco Papalia
Rocco Papalia
GSGiuseppe Simone
Giuseppe Simone
MFMariaconsiglia Ferriero
Mariaconsiglia Ferriero
SGSalvatore Guaglianone
Salvatore Guaglianone
Manuela CostantiniManuela Costantini
Manuela Costantini
MGMichele Gallucci
Michele Gallucci